Overview
Preclinical and Translational Nuclear Medicine
Please find the overview outlined below.
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases
Erik H. J. G. Aarntzen, Edel Noriega-Álvarez, Vera Artiko, André H. Dias, Olivier Gheysens, Andor W. J. M. Glaudemans, Chiara Lauri, Giorgio Treglia, Tim van den Wyngaert, Fijs W. B. van Leeuwen & Samantha Y. A. Terry
Guidelines to PET measurements of the target occupancy in the brain for drug development
Akihiro Takano, Andrea Varrone, Balázs Gulyás, Piero Salvadori, Antony Gee, Albert Windhorst, Johnny Vercouillie, Guy Bormans, Adriaan A. Lammertsma & Christer Halldin
Guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
Sergio Todde, Albert D. Windhorst, Martin Behe, Guy Bormans, Clemens Decristoforo, Alain Faivre-Chauvet, Valentina Ferrari, Antony D. Gee, Balazs Gulyas, Christer Halldin, Petra Kolenc Peitl, Jacek Koziorowski, Thomas L. Mindt, Martina Sollini, Johnny Vercouillie, James R. Ballinger & Philip H. Elsinga
Guideline to Regulations for Radiopharmaceuticals in Early Phase Clinical Trials in the EU
Alfons Verbruggen, Heinz H. Coenen, Jean-Robert Deverre, Denis Guilloteau, Bengt Langstrom, Piero A. Salvadori & Christer Halldin